detailed programme...claudia burz1, ovidiu balacescu2, oana tudoran2, loredana balacescu2, victor...

1

“PROF. DR. ION CHIRICUŢĂ” ONCOLOGY INSTITUTE

INTERNATIONAL CONFERENCE

FIRST CONFERENCE OF THE ROMANIAN DIVISION OF IAP

“THE PATHOBIOLOGY AND MOLECULAR BIOLOGY OF TUMORS”

CLUJ-NAPOCA ROMANIA28-30 APRIL, 2010

City Plaza Hotel

DETAILED PROGRAMME

2

TUESDAY, APRIL 27, 2010

16.00 – 18.00

REGISTRATION / CITY PLAZA HOTEL /MAIN LOBBY

WEDNESDAY, APRIL 28, 2010

7.30 – 8.45

REGISTRATION / CITY PLAZA HOTEL /MAIN LOBBY/POSTER MOUNTING

9.00 – 10.00

OFFICIAL OPENING CEREMONY

CITY PLAZA BALLROOM9.00 – 9.10

ALEXANDRU IRIMIE“PROF. DR. ION CHIRICUŢĂ” ONCOLOGY INSTITUTE, CLUJ-NAPOCA, ROMANIA – A POWERFUL CENTER IN PATHOLOGY

AND THERAPY OF CANCER

9.10 – 9.20

CLAUDIO LOMBARDO INAUGURAL FROM THE ORGANISATION OF THE EUROPEAN CANCER INSTITUTES

9.20 – 9.30

PETRE FLORESCUCONTINUOS MEDICAL EDUCATION – OR HOW TO BECOME A PROFESSIONIST IN PATHOLOGY

9.30 – 9.40

ANTONIO LLOMBART-BOSCHPATHOBIOLOGY WORKING GROUP – EXCELLENCE IN CANCER BIOLOGY AND TREATMENT

9.40 – 9.50

MARIA SAJINTHE MISSION OF THE ROMANIAN DIVISION OF IAP

9.50 – 10.00

ARETI DINULESCUTHE ROMANIAN SOCIETY OF PATHOLOGY: NEW CHALLENGES IN THE YEARS TO COME

10.00 – 10.20 / COFFEE BREAK

10.20 – 12.20 PLENARY SESSION I / CHAIRMAN: CLAUDIO LOMBARDO, ANTONIO LLOMBART BOSCH

10.20 – 11.00

BUILDING THE EUROPEAN AREA FOR CANCER RESEARCH

Claudio Lombardo

Special Assistant to the OECI President – National Institute for Cancer research of Genoa – Italy11.00 – 11.40

IMMUNOHISTOCHEMISTRY OF THE NEW MOLECULAR CLASSIFICATION OF BREAST CARCINOMA

Antonio Llombart Bosch, Isidro Machado, Antonio Llombart Cussac

Dpt. Pathology. University of Valencia and Dpt. Oncology Hosp. Arnau Vilanova Lleida, Spain11.40 – 12.20

MANAGEMENT OF SOFT TISSUE TUMOR SPECIMENS IN THE PATHOLOGY DEPARTMENT: PRACTICAL CONSEQUENCES

FOR DIAGNOSIS AND TREATMENT OF PATIENTS WITH SARCOMAS

Philippe Terrier

Institute Gustave Roussy, Villejuif, France

12.20 – 14.20 LUNCH TIME / POSTER SESSION 1 PATHOLOGY POSTER SESSION/CHAIRMAN: PHILIPPE TERRIER,

JOSÉ ANTONIO LÓPEZ-GUERRERO, RARES BUIGA - POSTER VIEWING

HISTOPATHOLOGICAL ASPECTS IN UTERIN CERVICAL CANCER1.

Izabella Sargan, Elena Pop, Roxana Folescu, Anca Muresan, Paul Ionut Stanciu, Stelian Pantea

“Victor Babeş” University of Medicine and Pharmacy, Timişoara, Romania

3

HISTOPATHOLOGICAL ASPECTS IN THYROID CANCER2.

Izabella Sargan, Elena Pop, Roxana Folescu, Anca Muresan, Paul Ionut Stanciu, Stelian Pantea

“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaHISTOLOGICAL ASPECT IN COLORECTAL CANCER3.

Roxana Folescu, Elena Pop, Izabella Sargan, Paul Ionut Stanciu, Stelian Pantea, Anca Muresan, Ecaterina Daescu

“Victor Babeş” University of Medicine and Pharmacy Timişoara, RomaniaQUANTIFYING INVASION GROUPS MEDIASTINAL LYMPH NODES IN LUNG CANCER4.

Roxana Folescu, Elena Pop, Izabella Sargan, Paul Ionut Stanciu, Stelian Pantea, Anca Muresan, Ecaterina Daescu

“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaPATHOLOGIC ANATOMICAL ASPECTS OF MALIGNANT OVARIAN TUMORS5.

Elena Pop, Izabella Sargan, Roxana Folescu, Paul Ionut Stanciu, Stelian Pantea, Alexandra Pop

“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaENDOMETRIOID CARCINOMA6.

Elena Pop, Izabella Sargan, Roxana Folescu, Paul Ionut Stanciu, Stelian Pantea, Alexandra Pop

“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaOVARIAN TUMORS OF MALIGNANCY LIMIT7.

Paul Ionut Stanciu, Stelian Pantea, Elena Pop, Roxana Folescu, Anca Muresan, Izabella Sargan

“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaTHE PREVALENCE OF TUMORAL SKIN MELANOCYTIC LESSIONS IN CHILDREN: A RETROSPECTIVE STUDY ON 58 8.

CASES

Loredana Beatrice Ungureanu1, Doina Mihaila2, Petru Plamadeala2, Mioara Trandafi rescu1, Adana Varna3

1University of Medicine and Farmacy “Gr. T. Popa” Iaşi, Morphopathology Department 2“St. Mary” Emergency Hospital for Children Iaşi, Pathology Laboratory 3City Hospital Tg. Frumos

USEFUL IMMUNOHISTOCHEMICAL TECHNIQUES FOR ELUCIDATING MINUTE ATYPICAL GLANDULAR9.

PROLIFERATIONS IN PROSTATE BIOPSY SPECIMENS – PRELIMINARY RESULTS

Alis Dema1, Denisa Anderco2, Sorina Taban1, Elena Lazar1, Maria Cornianu1, Codruta Lazureanu1, Diana Herman2, Anca

Muresan1, Remus Cornea1, Alexandra Faur1

1“Victor Babeş” University of Medicine and Pharmacy, Timişoara, Romania2Emergency County Hospital, Timişoara, Romania

CHANGING OF THE IMMUNOHISTOCHEMICAL PROFILE OF THE BREAST CANCER CELLS DURING CHEMOTHERAPY:10.

A TREATMENT CHALLENGE

Codruţa Lazureanu1,2, Elena Lazar1,2, Alis Dema1,3, Diana Herman3, Remus Cornea1

1 “Victor Babeş” University of Medicine and Pharmacy, Timişoara, Romania2City Hospital Timişoara 3County Hospital Timişoara

PLEOMORPHIC SARCOMA OF SOFT TISSUE WITH GIANT CELLS, AS IMUNOPHENOTIPICAL SYNOVIAL SARCOMA11.

Eugenia Moldovan, Anca Paulet, Jung Janos

Târgu Mureş County Emergency HospitalRELATIONSHIP BETWEEN CYCLOOXYGENASE – 2 EXPRESSION AND ANGIOGENESIS IN PATIENTS WITH GASTRIC 12.

CANCER

Sorina Taban, Daniela Lazar, Alis Dema, Elena Lazar, Marioara Cornianu, Codruta Lazureanu

“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaIMMUNOHISTOCHEMICAL EXPRESSION OF KI-67, P53 AND CYCLOOXYGENASE-2 IN GASTRIC CARCINOMA: 13.

CORRELATION WITH CLINICOPATHOLOGICAL FACTORS AND SURVIVAL

Sorina Taban, Daniela Lazar, Alis Dema, Elena Lazar, Marioara Cornianu, Alexandra Faur, Cornea R., Mirela Grigoras,

Delia Zahoi


PLENARY SESSION 2 / CHAIRMAN: KRISTIN HENRY, ELIAS CAMPO

14.20 – 15.00

LYMPHOMA DIAGNOSIS FROM MORPHOLOGY TO MOLECULAR GENETICS

Elias Campo

Hospital Clinic, University of Barcelona, Barcelona, Spain15.00 – 15.40

DENDRITIC CELL TUMOURS

Kristin Henry

Imperial College London, Charing Cross Hospital, London W6 8RF15.40 – 16.10

PATHOBIOLOGY VS. RADIOBIOLOGY IN CANCER TREATMENT: FOCUS ON RADIOGENOMICS

V. Cernea

“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania

16.10 – 16.20 / COFFEE BREAK

4

16.20 – 16.50

CIRCULATING TUMOR CELLS DETECTION IN BREAST AND GYNECOLOGIC CANCERS

Rares Buiga

“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania16.50 – 17.20

BLOOD ANGIOGENIC MARKERS AS NONINVASIVE DIAGNOSIS IN PROSTATE CANCER

Ovidiu Balacescu1, Oana Tudoran1, Loredana Balacescu1, Claudia Burz2, Nicolae Crisan3, Sorin Popescu1, Alexandru

Irimie1,2, Neagoe Ioana1,2

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania3County Hospital Cluj-Napoca17.20 – 17.50

CASTLEMAN’S DISEASE

Bogdan Fetica, Anca Popa, Alin Rancea, Andrei Cucuianu


19.30 – GALA DINNER – MARCO POLO RESTAURANT AT CITY PLAZA

THURSDAY, APRIL 29, 2010

PLENARY SESSION 3/CHAIRMAN: JOSÉ ANTONIO LÓPEZ-GUERRERO, GEORGE KONTOGEORGOS

9.00 – 9.40

MOLECULAR STAGING OF PROSTATE CANCER: THE ROLE OF THE NEW BIOMARKERS

José Antonio López-Guerrero

Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología Valencia, Spain9.40 – 10.20

RENAL CELL CARCINOMAS IN PATIENTS WITH RADIATION EXPOSURE FOLLOWING THE CHERNOBYL ACCIDENT

Antonio Llombart Bosch, Alina Romanenko,* Luisa Morell, José Antonio López-Guerrero**

Dpt. Pathology, Univ. Valencia, Spain, *Departments of Pathology and Urology, Institute of Urology, Academy of Medical Sciences, Kiev, Ukraine, **Molecular Biology Service IVO Valencia, Spain 10.20 – 10.50

MODERN APPROACH IN THE PATHOLOGY OF PROSTATE ADENOCARCINOMA

Petre Florescu

“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

10.50 – 11.00 / COFFEE BREAK

11.00 – 11.40

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETS)

George Kontogeorgos M.D., Ph.D.

Department of Pathology and Pituitary Tumor Reference Center, G. Gennimatas Athens General Hospital, Athens, Hellas 11.40 – 12.10

CRYOGLOBULINEMIC GLOMERULONEPHRITIS: CLINICO-BIOPTIC CORRELATIONS

C. Spanu1, P. Florescu1, Anca Cristea2, C. Craciun3

1“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania2County Hospital Cluj-Napoca3”Babeş-Bolyai” University, Cluj-Napoca, Romania12.10 – 12.50

APPLICATION OF ENDOSOMOLYTIC CELL-PENETRATING PEPTIDES FOR NUCLEIC ACID DELIVERY- APPLICATIONS AND

POTENTIAL IMPLICATION FOR CANCER TREATMENT

Samir EL Andaloussi1,3, Taavi Lehto2, Iulian Oprea3, CI Edvard Smith3 and Ülo Langel1,2

1Stockholm University, Department of Neurochemistry, 106 92 Stockholm, Sweden2Tartu University, Institute of Technology, 504 11 Tartu, Estonia3Karolinska Institute, Department of Laboratory Medicine, 141 86 Huddinge, Sweden

5

12.50 – 13.20

LYMPHANGIOGENESIS AS A POTENTIAL MARKER FOR TUMOR THERAPY

Marius Raica, Anca Maria Cimpean


13.20 – 14.40 LUNCH TIME/ POSTER SESSION 2 MOLECULAR BIOLOGY POSTER SESSION/CHAIRMAN:

CLAUDIO LOMBARDO, SAMIR EL ANDALOUSSI, IOANA NEAGOE - POSTER VIEWING

ANTIOXIDANT1. EFFECTS OF A GRAPE SEED EXTRACT (GSE)

Gabriela Chereches1, Corina Tatomir1, Doina Daicoviciu2, I.D. Postescu1

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

L-N-ACETYLCYSTEINE AGAINST AMINOGLYCOSIDES’ OTOTOXICITY IN THE ORGAN CULTURES OF RAT COCHLEA2.

Maria Perde-Schreppler1, Alma Maniu2, Marcel Cosgarea2


MECHANISMS OF APOPTOSIS INDUCED BY OXALIPLATIN IN COLORECTAL CANCER. PHARMACOGENOMICS STUDY3.

Claudia Burz1, Ovidiu Balacescu2, Oana Tudoran2, Loredana Balacescu2, Victor Cristea1, Sorin E. Leucuta1, Alexandru

Irimie1,2, Ioana Neagoe1,2

1“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania2“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania4. ARSENIC TRIOXIDE SENSITIZES CANCER STEM CELLS TO CONVENTIONAL CHEMOTHERAPY – A DIFFERENTIATION

THERAPY MODEL FOR HEPATOCELLULAR CARCINOMA

Ciprian Tomuleasa1·2, Olga Soritau1, Teodora Pop2·3, Eva Fischer-Fodor1, Ofelia Mosteanu2·3, Bogdan Pintea3, Piroska

Virag1, Gabriel Kacso1·2, Monica Acalovschi2·3, Alexandru Irimie1,2

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania33rd Medical Clinic, Cluj Napoca

APOPTOSIS INDUCED PATHWAYS BY RNA INTERFERENCE VEGF INHIBITION IN CERVICAL CANCER5.

O. Tudoran1,2, C. Braicu1, O. Soritau1, O. Balacescu1, L. Balacescu1, F. Irimie2, I. Neagoe 1,3

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2Faculty of Chemistry and Chemical Engineering3“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

p53 GENE THERAPY IN HUMAN CERVICAL CANCER CELL LINE6.

Cornelia Braicu1, Ioana Berindan Neagoe1,2, Roxana Redis2, Oana Tudoran1, Ovidiu Balacescu1, Alexandru Irimie1,2


TEMOZOLOMIDE ENHANCE NEOANGIOGENESIS OF GLIOBLASTOMA MULTIFORME IN A 3D ANGIOGENESIS ASSAY7.

Vasile Foris1, 2, Ciprian Tomuleasa1, 2, Olga Soritau1 , Dana Cernea1, Horatiu Ioani3, Stefan Florian 2,3

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania3Neurosurgery Clinic, Cluj County Hospital

PLACENTAL MESENCHYMAL STEM CELLS DIFFERENTIATION8.

Dan Rus Ciuca1, Olga Soritau2, Sergiu Susman3, Victor Pop4, Carmen Mihu3

1Emergency County Clinic Hospital Cluj-Napoca2“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania3“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

A STATIC CYTOMETRIC EVALUATION OF THE 9. EX VIVO TUMORAL CHEMOSENSITIVITY TO PLATINUM-BASED DRUGS

Eva Fischer-Fodor1, Olga Soritau1, Piroska Virag1, Rares Buiga1, Doris Pelau1, Cosmin Lisencu1, Otilia Barbos1, Natalia

Miklasova2, Yael Schiff enbauer3, Alexandru Irimie1

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2Faculty of Pharmacy, Comenius University in Bratislava, Slovakia3Cell Kinetics Laboratory, Lod, Israel

FUNCTIONAL GENOMICS STUDY IN PROSTATE CANCER10.

Loredana Balacescu1,3, Ovidiu Balacescu1, Nicolae Crisan2, Oana Tudoran1, Meda Rus1, Claudia Gherman1, Cornelia

Braicu1, Nicoale Dragos3, Ioana Neagoe1,4

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2Municipal Clinical Hospital, Cluj-Napoca, Romania3Faculty of Biology, “Babeş-Bolyai” University, Cluj-Napoca, Romania4“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

THE UTILITY OF FUNCTIONAL GENOMICS TECHNOLOGIES IN EXPERIMENTAL MODELS FOR CANCER RESEARCH11.

Claudia Gherman1, Cornelia Braicu1, Loredana Balacescu1, Ovidiu Balacescu1, Oana Tudoran1, Flaviu Dragla1, Gheorghe

Rapuntean3, Ioana Neagoe1,2

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania3University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania

6

MONITORING T315I MUTATION IN CHRONIC MYELOID LEUKEMIA BY ARMS PCR12.

D. Dima1, Trifa A.2, A. Cucuianu1, R.A. Popp2, M. Patiu1, L. Petrov1


THE13. JAK2 RS10974944 SNP, PART OF JAK2 46/1 HAPLOTYPE, IS STRONGLY ASSOCIATED WITH JAK2 V617F -

POSITIVE MYELOPROLIFERATIVE NEOPLASMS

Adrian P. Trifa1, Andrei Cucuianu2, Ljubomir Petrov2, Laura Urian2, Mariela Militaru1, Delia Dima2, Ioan V. Pop1, R.A.

Popp1

1“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania2“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania14. DNA METHYLATION IN CANCER

Roxana Redis2, Ovidiu Balacescu1, Ioana Neagoe1,2, Victor Ioan Pop2


PLENARY SESSION 4/CHAIRMAN: PETRE FLORESCU, EUGEN MANDACHE

14.40 – 15.00

MICRODISSECTION FROM CARL ZEISS: A NEW DIMENSION IN SAMPLE PURITY

Antje M. Pries, Carl Zeiss A.G., Germany15.00 – 15.30

IMMUNO-HISTOPATHOLOGICAL FEATURES IN HUMAN AND EXPERIMENTAL DIABETIC NEPHROPATHY

E. Mandache, M. Penescu

“Carol Davila” Clinical Hospital of Nephrology – Bucharest, “Victor Babeş” National Institute of Pathology – Bucharest15.30 – 16.00

THE ROLE OF THE BIOPSY IN PULMONARY PEDIATRIC PATHOLOGY

D. Gheban1, P. Florescu2, Bianca Urzica2

1Pediatric Emergency Hospital Cluj-Napoca2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania16.00 – 16.30

BORDERLINE OVARIAN LESIONS

Patriciu Achimas Cadariu1,2, Cosmin Lisencu1, Ioana Berindan Neagoe1,2, Rares Buiga, Emilian Neagoe1, Emil Puscas2,

Alexandru Irimie1,2

1 “Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

16.30 – 16.40 / COFFEE BREAK

16.40 – 17.10

VALIDATION OF NEW BIOMARKERS FOR CANCER THERAPY

Ioana Berindan Neagoe1,2, Ovidiu Balacescu1, Loredana Balacescu1, Oana Tudoran1, Claudia Burz2, Rares Buiga1, Patriciu

Achimas Cadariu1,2, Alexandru Irimie1,2

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2University of Medicine and Pharmacy Cluj Napoca17.10 – 17.40

CYTOTOXICITY AND CYTOGENETIC FEATURES OF OXALIPLATIN RESISTANT COLORECTAL CANCER CELL LINE

Piroska Virag, Eva Fischer-Fodor, Maria Perde-Schreppler, Ioana Brie, Corina Tatomir

“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania17.40 – 18.10

PREDICTION OF CLINICAL OUTCOME IN PATIENTS WITH CERVIX CARCINOMA BY PRE-THERAPEUTIC EVALUATION OF

DNA LESIONS

Ioana-Carmen Brie, Viorica Nagy, Piroska Virag, Maria Perde-Schreppler, Eva Fisher-Fodor, Vasile Foris, Nicolae Todor


DOCTOR HONORIS CAUSA CEREMONY FOR PROF. ANTONIO LLOMBART BOSCH

AT “IULIU HAŢIEGANU” UNIVERSITY OF MEDICINE AND PHARMACY CLUJ-NAPOCA (HOUR TO BE ANNOUNCED)

19.00 DINNER – CHIOS RESTAURANT

7

FRIDAY, APRIL 30, 2010

9.00 – 10.50 / SLIDE SEMINAR – FIRST SESSION

Note: each case shall be presented in maximum 10 minutes, following the next scheme: brief clinical context, important points for diagnosis, diagnosis, diff erentials.The organizers off ers an important number of microscopes to be used by the participants as well as a telepathology system (slidesshall be available on a web link before the conference) to give access to the specifi c cases involved in the seminar.

Case n° 1 – KRISTIN HENRY

Case n° 2 – KRISTIN HENRY

Case n° 3 – PETRE FLORESCU

Case n° 4 – ANTONIO LLOMBART-BOSCH

Case n° 5 – ANTONIO LLOMBART-BOSCH

Case n° 6 – MARIUS RAICA

Case n° 7 – PHILIPPE TERRIER

Case n° 8 – PHILIPPE TERRIER

Case n° 9 – ELIAS CAMPO

Case n° 10 – ELIAS CAMPO

10.50 – 11.00 / COFFEE BREAK

11.00 – 13.00 / SLIDE SEMINAR – SECOND SESSION

Case n° 11 – MARIA SAJIN

Case n° 12 – GEORGE KONTOGEORGOS

Case n° 13 – GEORGE KONTOGEORGOS

Case n° 14 – JUNG JANOS

Case n° 15 – JOSÉ ANTONIO LÓPEZ-GUERRERO

Case n° 16 – JOSÉ ANTONIO LÓPEZ-GUERRERO

Case n° 17 – EUGEN MANDACHE

Case n° 18 – DAN GHEBAN

Case n° 19 – RARES BUIGA

Case n° 20 – BOGDAN FETICA

13.00 – 15.00 LUNCH TIME/ POSTER SESSION 3 CLINICAL POSTER SESSION/CHAIRMAN: ELIAS CAMPO,

GEORGE KONTOGEORGOS, PATRICIU ACHIMAS - POSTER VIEWING

SPORADIC COLORECTAL CANCER OR HEREDITARY LYNCH SYNDROME: ANAMNESTIC EPIDEMIOLOGIC STUDY1.

USING AMSTERDAM AND BETHESDA CRITERIA

Simona Valean1, P.A. Mircea1, Doinita Crisan2, Magda Petrescu2

“Iuliu Haţieganu” University of Medicine and Pharmacy of Cluj-Napoca, RomaniaHOW TO BOOST THE BREAST TUMOR BED? FROM CONVENTIONAL TO 3D-CONFORMAL IN EARLY BREAST CANCER 2.

RADIOTHERAPY IN “PROF. DR. ION CHIRICUŢĂ” ONCOLOGY INSTITUTE RADIOTHERAPY DEPARTMENT

Daniela Martin, Cristina Vitoc, Gabriela Tufascu, V. Bogdan, D. Dordai, A. Chis, Carmen Lisencu, Cosmin Lisencu, A.

Rancea, R. Tanasescu, Carmen Popa, Dana Grecea, V. Cernea, N. Ghilezan

“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, RomaniaLAPAROSCOPY – MODERN TREATMENT IN CERVICAL CANCER3.

Paul Ionut Stanciu, Stelian Pantea, Elena Pop, Roxana Folescu, Anca Muresan, Izabella Sargan

“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaPHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA. THE EXPERIENCE OF HEMATOLOGY CLINIC CLUJ-4.

NAPOCA

Delia Dima1, Andrei Cucuianu1, Mariana Patiu1, Ljubomir Petrov1, Hartmut Dohner2

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania, Hematology Department2University of Ulm, Department of Internal Medecine III, Ulm, Germany

8

ACUTE MYELOID LEUKEMIA AND TYPE II DIABETES MELLITUS IN COMPLETE REMISSION AFTER ALLOGENEIC STEM 5.

CELL TRANSPLANTATION

Delia Dima1, Andrei Cucuianu1, Smaranda Arghirescu2

1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2„Louis Turcanu” Children’s Hospital Timişoara, Bone Marrow Transplantation Department

RISK FACTORS FOR INEFFECTIVE COPING IN ACUTE LEUKEMIA PATIENTS6.

Andrada Parvu

“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, RomaniaTHE TREATMENT WITH BORTEZOMIB IN MULTIPLE MYELOMA7.

Anca Bojan, Anca Vasilache, A. Cucuianu, Laura Urian, Mariana Patiu, Carmen Basarab, C. Coldea, Tunde Torok, M.

Zdrenghea, L. Petrov1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

UNUSUALLY LONG LASTING HEMATOLOGICAL REMISSION AND SURVIVAL IN A CASE OF CHRONIC MYELOID8.

LEUKEMIA TREATED WITH THREE DIFFERENT THYROSINE KINASE INHIBITORS.

L. Petrov, Laura Urian, Anca Vasilache, Anca Bojan, A. Cucuianu, Mariana Patiu, Carmen Basarab, C. Coldea

“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania & “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

MABTHERA IN TREATMENT OF NONHODGKIN LYMPHOMAS- PRESENTATION OF 27 CASES TREATED AT9.

HEMATOLOGY CLINICS CLUJ NAPOCA BETWEEN 2001 – 2009

Tunde Torok-Vistai, L. Petrov, A. Cucuianu, A. Bojan, L.Urian, A. Vasilache, M. Zdrenghea, A. Zsoldos

“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, RomaniaUNUSUAL ALTERNATIVE OF RICHTER SYNDROM: HODGKIN LYMPHOMA.10.

Laura Urian, Ljubomir Petrov, Cosmina Gavrilut, Anca Bojan, Carmen Basarab, Andrei Cucuianu, Mariana Patiu, Tunde

Torok, Anca Vasilache, Mihnea Zdrenghea

“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania

DEVELOPING A PREDICTIVE MODEL FOR TRANSFUSION REQUIREMENT FOR ACUTE LEUKEMIA PATIENTS11.

Andrada Parvu, Anca Bojan, Andrei Cucuianu, Laura Urian, Anca Vasilache, Tunde Torok, Mihnea Zdrenghea, Mariana

Patiu, Carmen Basarab, Delia Dima, Cosmina Gavrilut, Mihaela Grosan, Alina Cuc, Andrea Zsoldos, Anca Daniela, Mihai

Chirila, Ionel Rosu, Ljubomir Petrov


15.00 – 15.30 – CLOSING CEREMONY – DIPLOMA’S AWARD

ORGANISING COMMITTEE:

ALEXANDRU IRIMIE

ANTONIO LLOMBART BOSCH

IOANA NEAGOE

RARES BUIGA

VALENTIN CERNEA

PETRE FLORESCU

MARIA SAJIN

PATRICIU ACHIMAS CADARIU

SPONSORS:

detailed programme...claudia burz1, ovidiu balacescu2, oana tudoran2, loredana balacescu2, victor...

Documents